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■Introduction
Multiple ocular surgeries induce conjunctival
shrinkage and subconjunctival fibrous scar formations.
It is difficult to perform trabeculectomy following the
development of these ocular conditions. Spoerl et al.１）
reported that amniotic membrane cross-linked by
glutaraldehyde was a useful material for surface
reconstruction of the cornea and that the cross-linked
amniotic membrane was not dissolved by ocular
enzymatic digestion. Toda et al.２） recently reported a
dried amniotic membrane that was processed by a
“Hyper-dry” device. We developed a novel dried cross-
linked amniotic membrane (HDCL-AM) by combining
Toda’s and Spoerl’s methods１，２）. Using this HDCL-AM,
we treated a large conjunctival defect developed after
trabeculectomy with mitomycin C in a patient with
multiple failed trabeculectomy.
■Case report
A 74-year-old woman was referred to our clinic
because of elevated intraocular pressure of the left
eye. The patient complained of headache and ocular
discomfort in the left eye. The patient had previously
undergone extracapsule cataract extraction and five
failed trabeculectomy procedures during the past 15
years. On examination, her left intraocular pressure
was 36 mmHg despite treatment with topical instilla-
tions of antiglaucoma drug and oral acetazolamide.
Left visual acuity was 0.09, while the right visual
acuity was no light perception due to optic atrophy
following primary open-angle glaucoma. The patient
underwent trabeculectomy with 0.04% mitomycin C.
Two days postoperatively, a large conjunctival tear (4
×3 mm) with aqueous leakage developed at the center
of filtering bleb. The intraocular pressure of her left
eye was 2 mmHg. The patient received a HDCL-AM
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patch with the use of tissue adhesive. The bare
surface of the HDCL-AM patch was gradually covered
with conjunctival epithelia, and 2 weeks later, com-
pletely covered (Fig. 1a, b). There was no further
aqueous leakage. Left visual acuity was 0.2. The
intraocular pressure was 14 mmHg in the left eye.
During the 24-month follow-up period, there were no
remarkable changes.
<Prepareration of a hyper-dried cross-linked amniotic
membrane>
This study was approved by the Ethics Committee
of the University of Toyama, and informed consent of
the patients was obtained. Fresh human amniotic
membrane was obtained from seronegative donors
undergoing caesarian sections at Toyama University
Hospital. The amniotic membrane was washed with
sterile phosphate buffer saline. According to the
method described by Spoerl et al.１）, the fresh amniotic
membrane was cross-linked by 0.1% glutaraldehyde.
The cross-linked amniotic membranes were dried
using a Hyper-dry device (Sakura, Nagano, Japan)２）.
The hyper-dried cross-linked amniotic membrane
(HDCL-AM) was cut into 5 cm squares and packaged,
then sterilized by gamma-ray (25 kGy) irradiation (Fig.
2).
<Surgical procedure for repair of the conjunctival
defect>
The HDCL-AM was cut 7 mm by 7 mm, and the
dried membrane was inserted through the conjuncti-
val defect underneath the conjunctival bleb. After
drying with a cellulose sponge, tissue adhesive (2-octyl
cyanoacrylate) was applied to the surrounding area
inside the conjunctival defect edge. By pressing the
lesion with a cellulose sponge, the tissue adhesive was
dried.
■Discussion
Our patient had previously undergone multiple
filtering surgeries and suddenly developed a large
conjunctival defect with aqueous leakage 2 days after
Fig. 1a Fourteen days postoperatively, the cross-linked
amniotic membrane was secured underneath the
conjunctival bleb (black arrows).
Fig. 2 Sterilized, dried, amniotic membrane cross-linked by
glutaraldehyde. On hydration, it becomes flexible.
Fig. 1b Regenerative conjunctival epithelium layer(white
arrow) was seen over the implanted amniotic
membrane (black arrow).
Fig. 1c The inlaied HDCL-AM tissue was recognized on
anterior segment OCT 24 months after surgery
(white arrow).
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the most recent trabeculectomy with mitomycin C.
This history of multiple ocular surgeries seemed to be
responsible for the weakness of the conjunctival tissue.
Leaking filtering bleb is an emergency situation that
can result in serious ocular complications such as
hypotony, maculopathy, choroidal detachment and
endophthalmitis. Several surgical techniques to repair
the leaking bleb have been described, including
application of tissue adhesive, autologous blood
subconjunctival injection, suturing of free conjunctival
patch or amniotic membrane graft, and advancement
of conjunctival flap３～７）. None the less, the treatment of
bleb leak remains a challenging management problem.
We successfully treated a patient with combined
application of our HDCL-AM and tissue adhesive (2-
octyl cyanoacrylate). Kim et al.８）reported that 2-octyl
cyanoacrylate has a minimal histotoxic effect in ocular
tissue. In our patient, there have not been any
apparent adverse effects of the tissue adhesive.
We consider that our HDCL-AM may possess
several advantages for ophthalmic use. Our dry-state
amniotic membrane is easy to handle and cut to the
desired size and shape with scissors before application.
Because it can be preserved in dry state at room
temperature, it is convenient to use. On hydration, it
becomes flexible. Spoerl et al.1） reported that cross-
linking of amniotic membrane by glutaraldehyde could
increase the resistance to collagenase on the ocular
surface and the patch was not dissolved for months
after transplantation onto the ocular surface. In our
patient, the implanted HDCL-AM was not dissolved for
24 months, as shown on anterior segment OCT. There
was no adverse effect induced by the implanted HDCL
-AM. The long-term durability and minimal toxicity of
HDCL-AM may make it available as an implant for
glaucoma surgery.
Burman et al.９） reported that amniotic membrane
possesses properties that promote re-epithelialisation.
In our patient, conjunctival re-epithelialisation over the
HDCL-AM was noted. Further investigation of
conjunctival wound repair using our HDCL-AM is
needed.
In the present study, we successfully treated a case
showing a large conjunctival defect with bleb leaks,
using a combination of a single layer HDCL-AM inlay
and tissue adhesive. This simple easy technique may
be a promising alternative method to manage a large
conjunctival defect with leaking bleb after trabeculec-
tomy.
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